American Gastroenterological Association and MATTER announce first-of-its-kind digestive disease incubator (AGA)

The American Gastroenterological Association (AGA) and health-care incubator MATTER have teamed up to launch the first-ever digestive disease startup accelerator, kicking off this summer. Ten early-stage companies working on novel diagnostics, therapies, and patient-experience solutions for conditions ranging from IBS and Crohn’s disease to liver disorders and colorectal cancer will be selected for a six-month program. Participants will receive tailored mentorship from an AGA executive-in-residence, monthly workshops, access to MATTER’s mentor network, and strategic resources to help them scale. This initiative builds on AGA’s existing GI Opportunity Fund and aims to bridge the gap between emerging technology and clinical practice; applications open in summer 2025.